Skip to main content
. 2007 Dec 19;23(3):413–419. doi: 10.1007/s00467-007-0694-9

Table 2.

Clinical parameters before and after rituximab therapy (NS not significant)

Parameter Before rituximab therapy After rituximab therapy P
Total lymphocyte count 1044 ± 596 1734 ± 1535 NS
CD4+ lymphocytes 344 ± 217 556 ± 264 NS
CD19+ lymphocytes 243 ± 223 74 ± 71 0.005
Immunoglobulin IgG 1603 ± 848 1596 ± 1055 NS
Immunoglobulin IgM 273 ± 514 283 ± 531 NS
Upr/cr (mg/mg) 4.0 ± 3.5 0.6 ± 0.6 0.001
Serum albumin (g/dl) 2.6 ± 0.7 3.5 ± 0.6 0.001
Scr (mg/dl) 1.2 ± 0.4 0.6 ± 0.2 0.001
eGFR (ml/min/1.73m2) 86 ± 32 144 ± 37 0.0003
Corticosteroid dose (mg/m2 per day) 79 ± 26 13 ± 20 <0.0001
SLEDAI-2K score 47 ± 19 25 ± 14 0.0004